US9745281B2 - Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3,-diol compounds - Google Patents
Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3,-diol compounds Download PDFInfo
- Publication number
- US9745281B2 US9745281B2 US14/767,762 US201414767762A US9745281B2 US 9745281 B2 US9745281 B2 US 9745281B2 US 201414767762 A US201414767762 A US 201414767762A US 9745281 B2 US9745281 B2 US 9745281B2
- Authority
- US
- United States
- Prior art keywords
- polar solvent
- group
- palladium
- general formula
- benzene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- KWBFOGRRRBLUAQ-UHFFFAOYSA-N OC1=CC=C(C2(O)CCCCC2)C(O)=C1 Chemical compound OC1=CC=C(C2(O)CCCCC2)C(O)=C1 KWBFOGRRRBLUAQ-UHFFFAOYSA-N 0.000 description 8
- JHIVVAPYMSGYDF-UHFFFAOYSA-N O=C1CCCCC1 Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- WLEVNPGGAMAYLT-UHFFFAOYSA-N OC1=CC=C(C2(O)CCCCC2)C(O)=C1.OC1=CC=C(C2(O)CCCCC2)C(O)=C1 Chemical compound OC1=CC=C(C2(O)CCCCC2)C(O)=C1.OC1=CC=C(C2(O)CCCCC2)C(O)=C1 WLEVNPGGAMAYLT-UHFFFAOYSA-N 0.000 description 4
- LSEHCENPUMUIKC-UHFFFAOYSA-N OC1=CC=C(C2CCCCC2)C(O)=C1 Chemical compound OC1=CC=C(C2CCCCC2)C(O)=C1 LSEHCENPUMUIKC-UHFFFAOYSA-N 0.000 description 4
- FELXHQNFFXWXGX-UHFFFAOYSA-N OC1=CC=C(C2CCCCC2)C(O)=C1.OC1=CC=C(C2CCCCC2)C(O)=C1 Chemical compound OC1=CC=C(C2CCCCC2)C(O)=C1.OC1=CC=C(C2CCCCC2)C(O)=C1 FELXHQNFFXWXGX-UHFFFAOYSA-N 0.000 description 3
- NMOORNJPVWWFPR-UHFFFAOYSA-N CC1=CC=C(Br)C(OCC2=CC=CC=C2)=C1 Chemical compound CC1=CC=C(Br)C(OCC2=CC=CC=C2)=C1 NMOORNJPVWWFPR-UHFFFAOYSA-N 0.000 description 1
- KBHILNOQHHQMJE-UHFFFAOYSA-N CC1=CC=C(C2(O)CCCCC2)C(OCC2=CC=CC=C2)=C1.CC1=CC=C(C2(O)CCCCC2)C(OCC2=CC=CC=C2)=C1 Chemical compound CC1=CC=C(C2(O)CCCCC2)C(OCC2=CC=CC=C2)=C1.CC1=CC=C(C2(O)CCCCC2)C(OCC2=CC=CC=C2)=C1 KBHILNOQHHQMJE-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D309/06—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
Definitions
- the present invention relates to a process for the synthesis of 4-(heterocycloalkyl)-benzene-1,3-diol compounds corresponding to the following general formulae (I) and (II):
- X is an oxygen atom or a sulphur atom.
- the 2,4-dibenzyloxybromobenzene (2) then is reacted, in the presence of butyllithium, with the heterocycloalkanones of general formula (3a) or (3b) ( FIGS. 1 and 2 ) to yield the benzylic alcohols of the general formula (4a) or (4b), respectively.
- a first disadvantage of said process is the introduction of a sequence of protection/deprotection reactions of phenols by benzyl groups. Indeed, the need to protect the phenol functional groups of the compound (1) leads, firstly, to the addition of two steps in the synthesis of the compounds (I) and (II) and, secondly, to an unnecessary increase in the mass of the intermediates (2), (4a) or (4b), which is not suitable from an industrial point of view, in particular in terms of the economical use of atoms.
- said synthesis employs benzyl bromide, whose lachrymatory properties make it tricky to handle on an industrial scale.
- a second disadvantage of said synthetic pathway is the use, in the second step, of cryogenic conditions (butyllithium, about ⁇ 70° C.), which require suitable industrial equipment and, consequently, which makes said process more expensive.
- the present invention thus aims at solving the problems cited above by proposing a process for the synthesis of the 4-(heterocycloalkyl)-benzene-1,3-diol of general formula (I) or (II) with fewer steps, greater economy, greater simplicity and an ability be adapted to an industrial scale.
- the subject matter of the present invention relates to a process for the synthesis of a 4-(heterocycloalkyl)-benzene-1,3-diol corresponding to the general formula (I)
- X is an oxygen atom or a sulphur atom, characterized in that a compound corresponding to the general formula (7a)
- X is an oxygen atom
- X is an oxygen atom
- Another subject matter of the invention relates to a process for the synthesis of a 4-(heterocycloalkyl)-benzene-1,3-diol corresponding to the general formula (II)
- X is an oxygen atom or a sulphur atom, characterized in that a compound corresponding to the general formula (7b)
- the polar solvent used in the two processes above is selected from the group comprising alcohols such as methanol, for example, carboxylic acids such as acetic acid, for example, esters such as ethyl acetate, for example, ethers such as tetrahydrofuran, for example, water, and a mixture of said solvents.
- the alcohols are selected from methanol, ethanol and isopropanol.
- the non-polar solvent is selected from the group consisting of dichloromethane and dichloro-1,2-ethane.
- the palladium-based catalyst is selected from the group consisting of palladium on carbon, palladium hydroxide and palladium acetate.
- the hydrogen pressure applied in the processes of the invention is between 1 bar and 10 bar.
- the base is selected from the group comprising sodium hydroxide, potassium hydroxide, lithium hydroxide and metal alcoholates, preferably sodium methanolate and potassium tert-butylate.
- the base is sodium hydroxide or potassium hydroxide.
- the polar solvent is selected from the group comprising water and alcohols, preferably methanol, ethanol, and isopropanol.
- the polar solvent is water.
- the resorcinol and the heterocycloalkanone (3a) or (3b) are used in a resorcinol/heterocycloalkanone molar ratio between 1 and 8.
- X is an oxygen atom or a sulphur atom.
- the compound is selected from the group consisting of 4-(4-hydroxy-tetrahydro-pyran-4-yl)-benzene-1,3-diol and 4-(3-hydroxy-tetrahydro-pyran-3-yl)-benzene-1,3-diol.
- Said novel synthetic pathway uses the resorcinol (6) as the starting product, which is very advantageous economically compared with the price of the 2,4-dihydroxybromobenzene (1).
- the first step of said novel synthetic pathway is a novel step of coupling the resorcinol (6) with the heterocycloalkanones (3a) or (3b) in the presence of a base.
- the base used is preferably selected from the group comprising sodium hydroxide, potassium hydroxide, lithium hydroxide, and metal alcoholates such as sodium methanolate or potassium tert-butylate, for example.
- Said step is carried out in polar solvent, preferably in water or in alcohols, and, respectively, produces the compounds (7a) or (7b) directly.
- the alcohols are preferably selected from the group comprising methanol, ethanol and isopropanol.
- excess resorcinol (6) is preferably used to react on the heterocycloalkanone (3a) or (3b). More specifically, the resorcinol/heterocycloalkanone molar ratio is between 1 and 8, preferably between 2 and 4.
- the temperature at which said coupling step is carried out is another advantage of said novel synthetic pathway.
- said first step is carried out at room temperature, in water or in alcohols, which avoids the cryogenic step (about ⁇ 70° C.) of the process disclosed in WO 2010/063773.
- the reaction intermediates (7a) or (7b) are obtained in crystalline form after neutralisation of the medium, thus avoiding the need for purification steps. Therefore, separation on a chromatography column to isolate the reaction intermediates (7a) or (7b)
- a pH equal to 7 or a pH of 7 to 8.
- the pH is equal to 7.
- the second step of said novel synthetic pathway is a step of hydrogenation or reduction of the intermediates (7a) or (7b) in order to obtain the compounds of formula (I) or (II), respectively.
- the hydrogenation of the intermediates (7a) or (7b) is carried out in polar solvent.
- the preferred polar solvents are selected from the group comprising alcohols such as methanol, for example, carboxylic acids such as acetic acid, for example, esters such as ethyl acetate, for example, ethers such as tetrahydrofuran, for example, water, and a mixture of said solvents.
- the alcohols are preferably selected from the group comprising methanol, ethanol and isopropanol.
- Hydrogenation is carried out in the presence of a palladium-based catalyst.
- the preferred catalysts are selected from the group consisting of palladium on carbon, palladium hydroxide, palladium acetate, or any other reduction catalyst known to the skilled person.
- the hydrogen pressure applied is between 1 bar and 10 bar, preferably between 3 bar and 7 bar.
- the reduction of the intermediates (7a) or (7b) is carried out in nonpolar solvent.
- the preferred nonpolar solvents are selected from the group comprising dichloromethane and dichloro-1,2-ethane.
- the reduction is carried out in the presence of a reducing agent of the silicon hydride type and a Lewis acid.
- the preferred reducing agents are selected from the group consisting of triethylsilane, polymethylhydrosiloxane (PMHS), and any other silicon hydride known to the skilled person.
- the preferred Lewis acids are selected from the group consisting of boron trifluoride and complexes thereof, such as trifluoroborane etherate, for example.
- FIG. 1 Preparation of compounds of formula (I) described in WO 2010/063773
- FIG. 2 Preparation of compounds of formula (II) described in WO 2010/063773
- FIG. 3 Process for the preparation of the compounds of the invention of formula (I)
- FIG. 4 Process for the preparation of the compounds of the invention of formula (II)
- Said oil is solubilised in 1 liter of dichloromethane and employed in the following step.
- a mixture of 2.9 g (0.14 mol, 1 eq) of 4-(3-hydroxy-tetrahydro-pyran-3-yl)-benzene-1,3-diol in 60 ml of ethyl acetate and 6 ml of methanol in the presence of 580 mg (20% by weight) of 10% palladium on carbon is stirred under 5 bar of hydrogen at room temperature for 5 hours and then heated at 50° C. for 24 hours (formation of 10% of the product).
- 580 mg (20% by weight) of 10% palladium on carbon is added and the reaction mixture is heated at 60° C. under 5 bar of hydrogen for 6 days.
- 580 mg (20% by weight) of 10% palladium on carbon is added and the reaction mixture is heated at 60° C.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
wherein X can be an oxygen atom or a sulphur atom. Also described, is a method for the synthesis of the reactive intermediates of general formula (7a) or (7b)
Description
are finally obtained from the compounds of general formulae (4a) and (4b), respectively, by hydrogenation in methanol in the presence of hydrogen and of a palladium-based catalyst.
wherein X is an oxygen atom or a sulphur atom, characterized in that a compound corresponding to the general formula (7a)
reacts, when X is an oxygen atom, with hydrogen in the presence of a palladium-based catalyst in polar solvent or, when X is a sulphur atom, with a reducing agent of the silicon hydride type and a Lewis acid in nonpolar solvent. Preferably, X is an oxygen atom.
wherein X is an oxygen atom or a sulphur atom, characterized in that a compound corresponding to the general formula (7b)
reacts, when X is an oxygen atom, with hydrogen in the presence of a palladium-based catalyst in polar solvent or, when X is a sulphur atom, with a reducing agent of the silicon hydride type and a Lewis acid in nonpolar solvent.
wherein X is an oxygen atom or a sulphur atom, is obtained by reaction of resorcinol with a heterocycloalkanone corresponding to the general formula (3a)
wherein X is an oxygen atom or a sulphur atom, is obtained by reaction of resorcinol with a heterocycloalkanone corresponding to the general formula (3b)
wherein X is an oxygen atom or a sulphur atom. Preferably the compound is selected from the group consisting of 4-(4-hydroxy-tetrahydro-pyran-4-yl)-benzene-1,3-diol and 4-(3-hydroxy-tetrahydro-pyran-3-yl)-benzene-1,3-diol.
is not necessary, which is another advantage for the adaptation of said process to an industrial scale. It is preferable to have a pH equal to 7 or a pH of 7 to 8. Preferentially, the pH is equal to 7.
Claims (38)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/767,762 US9745281B2 (en) | 2013-02-14 | 2014-02-14 | Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3,-diol compounds |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361764638P | 2013-02-14 | 2013-02-14 | |
| FR1351252 | 2013-02-14 | ||
| FR1351252 | 2013-02-14 | ||
| US14/767,762 US9745281B2 (en) | 2013-02-14 | 2014-02-14 | Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3,-diol compounds |
| PCT/FR2014/050312 WO2014125231A1 (en) | 2013-02-14 | 2014-02-14 | Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3-diol compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20160185749A1 US20160185749A1 (en) | 2016-06-30 |
| US9745281B2 true US9745281B2 (en) | 2017-08-29 |
Family
ID=51353520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/767,762 Expired - Fee Related US9745281B2 (en) | 2013-02-14 | 2014-02-14 | Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3,-diol compounds |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9745281B2 (en) |
| EP (1) | EP2956449B1 (en) |
| ES (1) | ES2635290T3 (en) |
| WO (1) | WO2014125231A1 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010063773A1 (en) | 2008-12-02 | 2010-06-10 | Galderma Research & Development | Novel 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics |
-
2014
- 2014-02-14 US US14/767,762 patent/US9745281B2/en not_active Expired - Fee Related
- 2014-02-14 WO PCT/FR2014/050312 patent/WO2014125231A1/en active Application Filing
- 2014-02-14 ES ES14710599.3T patent/ES2635290T3/en active Active
- 2014-02-14 EP EP14710599.3A patent/EP2956449B1/en not_active Not-in-force
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010063773A1 (en) | 2008-12-02 | 2010-06-10 | Galderma Research & Development | Novel 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics |
Non-Patent Citations (3)
| Title |
|---|
| English Translation of the International Search Report dated Apr. 22, 2014 corresponding to International Patent Application No. PCT/FR2014/050312, 3 pages. |
| International Search Report and Written Opinion dated Apr. 22, 2014 corresponding to International Patent Application No. PCT/FR2014/050312, 10 pages. |
| Nitta, A., et al.,"(3R)-3-Amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothialzol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes," Bioorganic & Medicinal Chemistry Letters, Pergamon, Amsterdam, NL, vol. 18, No. 20, Oct. 2008, pp. 5435-5438. |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2635290T3 (en) | 2017-10-03 |
| US20160185749A1 (en) | 2016-06-30 |
| EP2956449A1 (en) | 2015-12-23 |
| WO2014125231A1 (en) | 2014-08-21 |
| EP2956449B1 (en) | 2017-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2770144C (en) | Process for the preparation of pyrazole carboxylic acid amides | |
| US20140039194A1 (en) | Process and intermediates for preparing integrase inhibitors | |
| EP2123624B1 (en) | Method for producing 4-methyl-2,3,5,6-tetrafluorobenzyl alcohol | |
| WO2016161826A1 (en) | Method for preparing 4-isopropylamino-1-butanol | |
| US9745281B2 (en) | Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3,-diol compounds | |
| US20220009899A1 (en) | Process and compounds for preparation of cannabinoids | |
| US8901361B2 (en) | Method for synthesizing 3,5-dichloroanisole from 1,3,5-trichlorobenzene | |
| JP6420673B2 (en) | Method for producing bis [4- (6-acryloyloxyhexyl) phenyl] cyclohexane-1,4-dicarboxylate | |
| US9650337B2 (en) | Method of synthesising 4-piperidin-4-yl-benzene-1,3-diol and the salts of same and novel compound tert-butyl 4-(2,4-dihydroxy-phenyl)-4-hydroxy-piperidine-1-carboxylate | |
| JP4609610B2 (en) | Process for producing 4-methylpyrazole-5-carboxylic acid compound | |
| CN119431211B (en) | Intermediate, and preparation method and application thereof | |
| RU2315747C2 (en) | Method for production of acetylene compound | |
| JP2010270092A (en) | Acetyl compound, method for producing the acetyl compound, and method for producing a naphthol compound using the acetyl compound | |
| CN109651325B (en) | Synthetic method of naphtho [1,2,3-de ] benzopyran-2, 7-diketone compound | |
| EP1700853A1 (en) | Processes for producing tetrahydropyran-4-one and pyran-4-one | |
| JP5291335B2 (en) | Tricine production method | |
| US6852867B2 (en) | Process for preparation of a benzofuran derivative | |
| CN119684100A (en) | A kind of preparation method of acetylglucerone | |
| SK287721B6 (en) | Process for producing quinoline carboxyaldehyde derivative and intermediate thereof | |
| US10633314B2 (en) | Method for the conversion of Abienol to Sclarediol | |
| CN116239630A (en) | A kind of dehydrated icariin intermediate compound | |
| CN120682150A (en) | A method for synthesizing the fungicide fluopicolide | |
| JP3144921B2 (en) | Benzyl ester derivative and method for producing the same | |
| JP4641772B2 (en) | Method for producing furanone | |
| KR100570279B1 (en) | Intermediates of coenzyme Qn and methods for preparing the intermediate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: GALDERMA RESEARCH & DEVELOPMENT, FRANCE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOITEAU, JEAN-GUY;REEL/FRAME:036668/0322 Effective date: 20150831 |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |
|
| FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |